Tag: aquabounty

FDA Completes Review of First Genetically Modified Animal for Consumption

By Veronique Greenwood | October 11, 2011 4:12 pm

The AquAdvantage salmon.

When most people say “genetically modified organism,” they usually mean a plant—corn, perhaps, or an eggplant. But that may soon change. The FDA has completed its analysis of the first genetically modified animal likely to hit supermarket shelves: the AquAdvantage salmon, made by Massachusetts-based AquaBounty Technologies, Inc. Thanks to some added genes, the salmon grows 2-6 times the size of a normal Atlantic salmon in half the time, promising some respite for the planet’s heavily taxed natural fish stocks, a third of which are near extinction or exhaustion. Talking Points Memo’s IdeaLab reports that a source close to the review process says that the FDA’s environmental impact statement, which looks at what effect the salmon will have on the environment and seems to be favorable, has been passed on to the White House’s Office of Management and Budget.

As always with genetically modified organisms, there are questions about how the salmon’s manufacturers plan to keep its genes from getting loose in the environment. AquaBounty has developed a way to make the fish sterile, which would make spreading their genes quite tricky. At the moment, however, it only works on 98% of the salmon. Additionally, the company is only seeking approval for growing the fish in large, land-locked tanks with double-thick walls. While giant nets teeming with fish in the middle of the ocean are a sight more commonly associated with aquaculture, inland tanks make the risk of modified fish escaping much smaller.

One hopes that if the fish is approved, though, the companies building the tanks make sure to avoid floodplains. Read more at IdeaLab.

Image courtesy of AquaBounty

FDA Committee Punts on Question of Biotech Fish

By Jennifer Welsh | September 21, 2010 9:23 am

salkmon-avlxyzAn FDA advisory panel has decided what it thinks about genetically modified salmon, and its decision is to not make a decision. The committee says it doesn’t have enough data to fully support approving the biotech salmon, which would make it the first such animal in the country.

“We are missing data,” said panel member James McKean, a professor at Iowa State University. He said that “leaves a cloud” over the FDA staff’s analysis. [Wall Street Journal]

But some other panel members agreed with the FDA’s position that the fish was fine.

“In conclusion, all of the data and information we reviewed … really drive us to the conclusion that AquAdvantage salmon is Atlantic salmon, and food from AquAdvantage salmon is as safe as food from other Atlantic salmon,” said Kathleen Jones of the FDA’s Center for Veterinary Medicine. [ABC News]

Read More

CATEGORIZED UNDER: Environment, Living World, Technology

Discover's Newsletter

Sign up to get the latest science news delivered weekly right to your inbox!


80beats is DISCOVER's news aggregator, weaving together the choicest tidbits from the best articles covering the day's most compelling topics.

See More

Collapse bottom bar